Lorena Monarrez, MD | |
1441 Constitution Blvd, Salinas, CA 93906-3100 | |
(831) 755-6268 | |
Not Available |
Full Name | Lorena Monarrez |
---|---|
Gender | Female |
Speciality | Emergency Medicine |
Experience | 17 Years |
Location | 1441 Constitution Blvd, Salinas, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104156355 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | A109938 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Natividad Medical Center | Salinas, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cep America - California | 6103739131 | 954 |
News Archive
Roswell Park Cancer Institute (RPCI) has received U.S. Food and Drug Administration (FDA) approval to enroll patients in a phase II clinical trial that will use a unique and highly precise method of delivering interstitial photodynamic therapy (I-PDT) to recurrent tumors of the head and neck.
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
A majority of college students is receptive to donating blood or other genetic material for scientific research, according to a new study from Southern Methodist University, Dallas.
› Verified 7 days ago
Entity Name | Cep America - California |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Roswell Park Cancer Institute (RPCI) has received U.S. Food and Drug Administration (FDA) approval to enroll patients in a phase II clinical trial that will use a unique and highly precise method of delivering interstitial photodynamic therapy (I-PDT) to recurrent tumors of the head and neck.
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
A majority of college students is receptive to donating blood or other genetic material for scientific research, according to a new study from Southern Methodist University, Dallas.
› Verified 7 days ago
Entity Name | County Of Santa Clara |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699885079 PECOS PAC ID: 1254244973 Enrollment ID: O20040113000784 |
News Archive
Roswell Park Cancer Institute (RPCI) has received U.S. Food and Drug Administration (FDA) approval to enroll patients in a phase II clinical trial that will use a unique and highly precise method of delivering interstitial photodynamic therapy (I-PDT) to recurrent tumors of the head and neck.
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
A majority of college students is receptive to donating blood or other genetic material for scientific research, according to a new study from Southern Methodist University, Dallas.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Lorena Monarrez, MD 1441 Constitution Blvd, Salinas, CA 93906-3100 Ph: (831) 755-6268 | Lorena Monarrez, MD 1441 Constitution Blvd, Salinas, CA 93906-3100 Ph: (831) 755-6268 |
News Archive
Roswell Park Cancer Institute (RPCI) has received U.S. Food and Drug Administration (FDA) approval to enroll patients in a phase II clinical trial that will use a unique and highly precise method of delivering interstitial photodynamic therapy (I-PDT) to recurrent tumors of the head and neck.
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of liver disease associated with AAT deficiency. These data were presented at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, "The Liver Meeting") held November 9-13, 2012 in Boston.
A majority of college students is receptive to donating blood or other genetic material for scientific research, according to a new study from Southern Methodist University, Dallas.
› Verified 7 days ago
Dr. Erica Locke, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 E Romie Ln, Salinas, CA 93901 Phone: 831-759-1840 | |
Rakesh Singh, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 450 E Romie Ln, Salinas, CA 93901 Phone: 831-759-1840 Fax: 831-753-6286 | |
Ruth L Selvidge, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1441 Constitution Blvd, Salinas, CA 93906 Phone: 831-647-7611 | |
Dr. Stephen Gregory Meigher, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 E Romie Ln, Salinas, CA 93901 Phone: 831-757-4333 | |
Catherine Dixon Ferguson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 E Romie Ln, Salinas, CA 93901 Phone: 831-757-4333 | |
Michael Gene Moeller, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1441 Constition Blvd, Salinas, CA 93906 Phone: 831-796-1603 |